VanEck Biotech Net Asset vs. Five Year Return

BBH Etf  USD 166.33  0.68  0.41%   
Considering the key profitability indicators obtained from VanEck Biotech's historical financial statements, VanEck Biotech ETF may not be well positioned to generate adequate gross income at the present time. It has a very high likelihood of underperforming in April. Profitability indicators assess VanEck Biotech's ability to earn profits and add value for shareholders.
For VanEck Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VanEck Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VanEck Biotech ETF utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VanEck Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VanEck Biotech ETF over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

VanEck Biotech ETF Five Year Return vs. Net Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth.
VanEck Biotech ETF is the top ETF in net asset as compared to similar ETFs. It is the top ETF in five year return as compared to similar ETFs . The ratio of Net Asset to Five Year Return for VanEck Biotech ETF is about  75,939,683 . Comparative valuation analysis is a catch-all model that can be used if you cannot value VanEck Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VanEck Biotech's Etf . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Biotech's earnings, one of the primary drivers of an investment's value.

VanEck Five Year Return vs. Net Asset

Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

VanEck Biotech

Net Asset

 = 

Current Market Value

-

Current Liabilities

 = 
478.42 M
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

VanEck Biotech

Five Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
6.30 %
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.

VanEck Five Year Return Comparison

VanEck Biotech is currently under evaluation in five year return as compared to similar ETFs.

VanEck Biotech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in VanEck Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, VanEck Biotech will eventually generate negative long term returns. The profitability progress is the general direction of VanEck Biotech's change in net profit over the period of time. It can combine multiple indicators of VanEck Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.

VanEck Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on VanEck Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of VanEck Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the VanEck Biotech's important profitability drivers and their relationship over time.

Use VanEck Biotech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VanEck Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will appreciate offsetting losses from the drop in the long position's value.

VanEck Biotech Pair Trading

VanEck Biotech ETF Pair Trading Analysis

The ability to find closely correlated positions to VanEck Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VanEck Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VanEck Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VanEck Biotech ETF to buy it.
The correlation of VanEck Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VanEck Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VanEck Biotech ETF moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VanEck Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your VanEck Biotech position

In addition to having VanEck Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Goods Thematic Idea Now

Consumer Goods
Consumer Goods Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Consumer Goods theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Goods Theme or any other thematic opportunities.
View All  Next Launch
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out Trending Equities.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for VanEck Etf analysis

When running VanEck Biotech's price analysis, check to measure VanEck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VanEck Biotech is operating at the current time. Most of VanEck Biotech's value examination focuses on studying past and present price action to predict the probability of VanEck Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VanEck Biotech's price. Additionally, you may evaluate how the addition of VanEck Biotech to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
To fully project VanEck Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of VanEck Biotech ETF at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include VanEck Biotech's income statement, its balance sheet, and the statement of cash flows.
Potential VanEck Biotech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although VanEck Biotech investors may work on each financial statement separately, they are all related. The changes in VanEck Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VanEck Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.